Pagliarosi Olivia, Pepe Jessica, Del Fattore Andrea, Rossi Michela
Department of Clinical, Internal, Anesthesiology and Cardiovascular Sciences, Sapienza University, Rome, Italy.
Bone Physiopathology Research Unit, Translational Pediatric and Clinical Genetic Research Division, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Front Endocrinol (Lausanne). 2025 Aug 19;16:1654497. doi: 10.3389/fendo.2025.1654497. eCollection 2025.
The "vanishing bone disease" or Gorham-Stout disease (GSD) is a very rare disorder characterized by massive lymphatic and angiomatous proliferation accompanied by progressive osteolysis, without the deposition of new bone matrix. Because of its rare and complex clinical features, diagnosis is challenging and its etiopathogenesis is not completely known; the genetic basis of GSD has been hypothesized and different mutations have been reported in patients. Our review aims to describe all these genetic alterations found in GSD patients and their association with clinical features. The identification of a specific molecular pathway or genetic alteration in GSD could help in the diagnosis and possibly the treatment of this rare sporadic disease.
“骨质消失病”或戈勒姆-斯托特病(GSD)是一种极为罕见的病症,其特征为大量淋巴管和血管瘤样增生,并伴有进行性骨质溶解,且无新骨基质沉积。由于其罕见且复杂的临床特征,诊断颇具挑战性,其病因发病机制也尚未完全明确;GSD的遗传基础已被提出假说,且在患者中报告了不同的突变。我们的综述旨在描述在GSD患者中发现的所有这些基因改变及其与临床特征的关联。确定GSD中特定的分子途径或基因改变可能有助于诊断,甚至可能有助于治疗这种罕见的散发性疾病。